Search results for: cancer
Inova Schar Cancer named top recruiter to innovative ER+ HER2- breast cancer clinical trial
Inova Schar Cancer is one of the top recruiting locations for the EMBER-4 clinical trial, a global study to evaluate a new treatment for ER+ HER2- breast cancer survivors EMBER-4 is a Phase 3 clinical trial comparing a new drug therapy, imlunestrant, to the standard drug therapy to treat women with ER+ HER2- breast cancer.…
Read MoreBESPOKE clinical trial supports value of blood test for colon cancer recurrence
The BESPOKE clinical trial evaluated molecular markers in blood samples as a guide that physicians can use to determine the benefit of chemotherapy for stage II and III colon cancer According to the Centers for Disease Control and Prevention, more than 126,000 new cases of colon cancer (colorectal cancer) were diagnosed in 2020. Colon cancer…
Read MoreInova, VCU and Sentara partner as part of new NIH research network evaluating emerging cancer screening technologies
Falls Church, VA – Three Virginia health systems together will serve as one of eight groups in the U.S. to conduct groundbreaking research for the Cancer Screening Research Network (CSRN), launched this week by the National Cancer Institute (NCI), part of the National Institutes of Health. The new clinical trials network creates a national infrastructure…
Read MoreCan certain foods reduce your risk of getting cancer?
It is difficult to browse the internet or social media, especially in the new year, without coming across the term “superfood.” Surprisingly, this is not a new term. The earliest recorded use of superfood was in the early 20th century by the United Fruit Company in its quest to market bananas. The use of the…
Read MoreCancer-free “Voice of DC” shares message of hope
Known as the “Voice of DC,” WTOP reporter Neal Augenstein continues to share his inspiring journey from a stage-4 lung cancer diagnosis in November 2022 to becoming cancer-free a year later. Last week, Neal’s story of the ground-breaking medical treatment he received at Inova Schar Cancer was featured on NBC News. In the piece, Amit…
Read MoreLung cancer screening at Saville Center: Less time, less worry for patients
Amit Mahajan, MD is board certified in pulmonary disease and critical care medicine. He serves as the medical director of interventional pulmonology and the complex airways disease program at Inova Fairfax Medical Campus. Lung cancer screening takes time. And that time often turns into stress for patients and their loved ones. That’s one reason that…
Read MoreLung cancer screening guidelines could save thousands of lives
Michael Weyant, MD, is a specialty care physician board-certified in thoracic surgery and general surgery who has special expertise in robotic minimally invasive surgery, lung cancer and thoracic surgery. He joined Inova Health System as the system-wide director of the thoracic surgery program in 2021 and has been practicing surgery since 1996. Lung cancer is…
Read MoreCancer survivorship programs at Inova – Life with Cancer and the new Survivorship Clinic
Lauren Broschak, MSW, LCSW, OSW-C, is an oncology-certified Licensed Clinical Social Worker at Life with Cancer. She serves as the Survivorship Program Manager at Inova Schar Cancer Life with Cancer. Her areas of interest include adolescent and young adults impacted by cancer, illness’ effect on sexuality, intimacy and fertility, couples and cancer, dating and cancer,…
Read MoreDebunking breast cancer myths
Teja Poosarla, MD is a board-certified medical oncologist specializing in the management of breast cancer at Inova Schar Cancer. She has been the principle investigator and has collaborated in multiple breast clinical trials. There are myths around breast cancer that we tend to take as established facts. This may lead us to make certain decisions…
Read MoreRepurposed Skin Cancer Drug Effective for Rare Brain Cancer
A multi-institutional study has identified a new treatment option for papillary craniopharyngioma, a rare form of cancer that forms along the central nervous system. “Brain tumors are rare, and papillary craniopharyngioma tumors are rare among this group,” said Adam Cohen, M.D., co-director of the neuro-oncology program at the Inova Schar Cancer Institute. “We found that…
Read More